Compare COFS & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COFS | OCGN |
|---|---|---|
| Founded | 1898 | 2013 |
| Country | United States | United States |
| Employees | 598 | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 462.9M | 492.5M |
| IPO Year | 1995 | 2014 |
| Metric | COFS | OCGN |
|---|---|---|
| Price | $30.91 | $1.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $34.00 | $9.75 |
| AVG Volume (30 Days) | 56.5K | ★ 7.5M |
| Earning Date | 04-24-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | N/A | ★ 31.58 |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $227,624,000.00 | N/A |
| Revenue This Year | $22.13 | N/A |
| Revenue Next Year | $4.47 | $1,718.38 |
| P/E Ratio | $15.44 | ★ N/A |
| Revenue Growth | ★ 63.64 | N/A |
| 52 Week Low | $26.10 | $0.73 |
| 52 Week High | $33.58 | $2.73 |
| Indicator | COFS | OCGN |
|---|---|---|
| Relative Strength Index (RSI) | 56.45 | 38.09 |
| Support Level | $29.38 | $1.32 |
| Resistance Level | $32.43 | $1.95 |
| Average True Range (ATR) | 0.82 | 0.09 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 60.09 | 16.35 |
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").